Following fields are empty!

1
Search
2
Select
3
Submit
209
Journals
Go to Previous Page
Page 10 of 11
Go to Next Page

Request Journal

Please fill in the form to request a new journal to be added. We will review your request and add it to the Journal Guide as soon as possible.

*

Reaction Chemistry & Engineering

eISSN: 2058-9883
SIGAPS Level C
Publisher: Royal Society of Chemistry
Visit Publisher homepageVisit journal homepageView author guidelinesView aims and scope
Chemical Engineering(all)Chemical Engineering (miscellaneous)BioengineeringCatalysisChemical Health and SafetyColloid and Surface ChemistryFiltration and SeparationFluid Flow and Transfer ProcessesProcess Chemistry and TechnologyChemistry (miscellaneous)Biomedical Engineering

Reaction Chemistry & Engineering is an interdisciplinary journal reporting cutting-edge research focused on enhancing the understanding and efficiency of reactions. Reaction Chemistry & Engineering is a unique forum for researchers whose interests span the broad areas of chemical engineering and chemical sciences to come together in solving problems of importance to wider society. Papers that consider multiple scales, from the laboratory up to and including plant scale, are particularly encouraged.

Read more
Loading data ...
Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

List Price

GBP 3,000.00

List Price

GBP 3,000.00
Go to Journal

Recent Patents on Drug Delivery and Formulation

ISSN: 1872-2113
Publisher: Bentham Science Publishers
Visit Publisher homepageVisit journal homepage
Biomedical EngineeringMedicine(all)Pharmacology, Toxicology and Pharmaceutics(all)Pharmaceutical Science

Recent Patents on Drug Delivery & Formulation publishes editorials, full-length research articles, short technical notes and guest-edited issues from the academia, industry, and regulatory agencies worldwide, and reviews and mini-reviews with a sharper focus on selected recent patents and patent applications. The journal’s scope covers topics related to preformulation, formulation development, manufacturing technologies, biopharmaceutics, and regulatory science, which include but are not limited to, pharmaceutical nanotechnology, quality by design and process analytical technology, biosimilars and biowaivers, simulation modeling, and intellectual property. Journal’s ambition is to serve as a bridge between academia and industry to stimulate the development of innovative technologies and products for various applications in the field of pharmaceutical and biotechnology sciences.

Read more
Loading data ...
Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Go to Journal

Regenerative Engineering and Translational Medicine

ISSN: 2364-4133eISSN: 2364-4141
SIGAPS Level D
Publisher: Springer
Visit Publisher homepageVisit journal homepage
Cell BiologyEngineering(all)Biomedical EngineeringBiomaterialsMedicine (miscellaneous)
Loading data ...
Compliant Options - Provided by Journal Checker Tool

Hybrid Journal

Go ahead and submit. Remember to select a CC BY licence to ensure compliance.

Transformative Agreement

Select the open access publishing option with a https://creativecommons.org/licenses/by/2.0/ license to ensure compliance.

Transformative Journal

Select the open access publishing option with a CC BY license to ensure compliance.

Full Open Access

Go ahead and submit. Remember to select a CC BY license to ensure compliance.

Self-Archiving

Following acceptance, please deposit your author accepted manuscript in a repository without embargo.

Self-Archiving using Rights Retention

Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.

Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool

Institutional Agreement

Les auteurs correspondants des Hospices Civils de Lyon ont la possibilité de publier leurs articles de recherches en Open Access dans cette revue. Pour bénéficier de cette prise en charge, déclarez les "Hospices Civils de Lyon" dans votre affiliation principale et utilisez votre adresse mail "@chu-lyon.fr" lors de la soumission de votre article.

L'éditeur précise les consignes suivantes à respecter lors de la soumission via sa plateforme:

  1. Utilisez votre adresse mail "@chu-lyon.fr" lors de la soumission de votre article
  2. Vérifiez que les Hospices Civils de Lyon apparaissent bien dans la zone "Institution"
  3. Liez votre ORCID à votre compte
  4. Si possible, réalisez la soumission depuis un ordinateur relié au réseau des HCL

ATTENTION:

  • Si l'éditeur vous demande de sélectionner la licence applicable, privilégiez la licence CC-BY à toutes autres.
  • L'accord porte uniquement sur les types d'articles suivants: "Article original", "Article de synthèse".
  • Veuillez noter que les types d'articles suivants ne sont pas couverts par cet accord : "Communication brève" et "Formation continue".
  • Cet accord ne concerne pas les revues Nature et BioMed Central (BMC).
  • Les articles publiés en accès ouvert immédiat au titre de l’accord peuvent être déposés dans leur version finale éditeur dans une archive ouverte, par exemple dans HAL-HCL.
  • Dans le cas des articles sous abonnement, il est permis par la Loi République numérique de déposer dans une archive ouverte le manuscrit auteur accepté d’un article et de le diffuser avec un embargo de 6 mois (sciences dures) ou 12 mois (SHS).

Si vous rencontrez des difficultés ou si vous avez des questions, contactez la Documentation Centrale sur sa.documentationcentrale@chu-lyon.fr ou au 04-72-11-29-99 (31-29-99)